Gentag believes that wearable biosensors linked with NFC devices have the power to transform medical and consumer diagnostics. We first patented the concept of an electronic “second skin” over a decade ago.

NFC Skin Patches

From the National Labs to Hospitals and Homes

Radar Responsive Tags, a sophisticated geolocation and tracking technology, are capable of precision locating items or individuals over large areas. First developed at the US National Laboratories for the Department of Defense, these tiny wireless chips, combined with sensors, are capable of providing exquisite location services.

Advanced Geolocation

This is a text block. Click the edit button to change this text.

Working to reduce costly hospital readmissions

By linking patients, wearable biological sensors that can be read with an encrypted NFC device, and doctors or hospitals, Gentag is working to reduce costly hospital readmissions, simplify patient discharge, and enable easy in-home self-monitoring.

Discharge Kits


  • “Sweating the big stuff” – Gentag mentioned in September 19th print edition of The Economist

    September 18, 2015

    Gentag’s pain-free wearable diabetes patch technology was mentioned in an article that appeared in the September 19th print edition of The Economist. For the full article, please visit:

    Read more
  • Gentag, Mayo Clinic, NovioSense and Fraunhofer Join Forces to Lower the Cost of Diabetes Care Globally

    July 14, 2015

    WASHINGTON, ROCHESTER, Minn., NIJMEGEN, Netherlands and DUISBURG, Germany, July 14, 2015 /PRNewswire/ — Exciting, new, patented technology platform poised to disrupt diabetes care delivery globally Extremely low-cost, pain-free system could be a game changer  No more lancets, glucometers Real-time cloud-based readings deliverable to caregivers and providers anywhere instantly via NFC cell phones Opportunity to improve diabetes outcomes worldwide Building on the long-standing collaboration between Gentag and Mayo Clinic, and the long-standing collaboration between NovioSense and Fraunhofer Institute for Microelectronic Circuits and Systems (IMS), Gentag and NovioSense today announced that they have formed a joint venture to combat the epidemic of type 2 diabetes that is...

    Read more
  • Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes

    March 4, 2015

    ROCHESTER, Minn. — Mayo Clinic and Gentag, Inc. have reached an agreement to develop the next generation of wearable biosensors designed to fight obesity and diabetes. “We are hoping that this technology will be game-changer. These patch biosensors may help us reduce global obesity and diabetes,” says James Levine, M.D., Ph.D., a Mayo Clinic endocrinologist and obesity researcher. “They are accurate, inexpensive, and can be integrated into the care people receive.” A first-of-its-kind, the wearable patch sensors are the size of a small bandage, and are designed to be painless, wireless and disposable. In the bandage is a sensor that communicates via a closed-loop diabetes...

    Read more